Lecanemab FDA Approval.

Lecanemab FDA Approval.

Dr. Watson, the world’s leading investigator for the Lecanemab compound, letter and statement on the FDA approval of Lecanemab. We are all ecstatic here at ARTC with the approval of the Lecanemab. This is the first disease modifying treatment to be approved anywhere...
Lecanemab in Early Alzheimer’s Disease.

Lecanemab in Early Alzheimer’s Disease.

Dr. David Watson of ARTC is one of the primary author’s of this article on Lecanemab and Alzheimer’s Disease. The accumulation of soluble and insoluble aggregated amyloid-beta (Aβ) may initiate or potentiate pathologic processes in Alzheimer’s disease....